Savior LLC Gilead Sciences, Inc. Transaction History

Savior LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 12, 2022	SELL	$57.92 - $72.58 $57 - $72	-1 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$64.88 - $73.64 $64 - $73	1 New	1 $0
Q3 2021 Oct 05, 2021	SELL	$67.69 - $73.03 $6,362 - $6,864	-94 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $396 - $451	-7 Reduced 6.93%	94 $5,000
Q2 2020 Jul 28, 2020	SELL	$72.34 - $84.0 $10,416 - $12,096	-144 Reduced 58.78%	101 $8,000
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $6,012 - $7,701	-96 Reduced 28.15%	245 $18,000
Q4 2019 Jan 22, 2020	BUY	$61.62 - $67.78 $21,012 - $23,112	341 New	341 $22,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

Stay updated on Savior LLC with notifications on news.